Celyad Oncology SA (EBR:CYAD)
Belgium · Delayed Price · Currency is EUR 0.2200
-0.0100 (-4.35%)
Last updated: Oct 24, 2025, 11:59 AM CET
Celyad Oncology Market Cap
Celyad Oncology has a market cap or net worth of €9.53 million as of October 24, 2025. Its market cap has decreased by -14.13% in one year.
Market Cap
9.53M
Enterprise Value
9.58M
Revenue
186.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.22
Market Cap Chart
Since July 4, 2013, Celyad Oncology's market cap has decreased from 101.99M to 9.53M, a decrease of -90.65%. That is a compound annual growth rate of -17.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 9.53M | -67.68% |
| Dec 31, 2024 | 29.50M | 82.56% |
| Dec 29, 2023 | 16.16M | 41.33% |
| Dec 30, 2022 | 11.43M | -85.60% |
| Dec 31, 2021 | 79.42M | -13.96% |
| Dec 31, 2020 | 92.30M | -31.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 46.57B |
| argenx SE | 43.40B |
| Financière de Tubize | 10.10B |
| Fagron NV | 1.55B |
| Ion Beam Applications | 326.62M |
| Onward Medical | 229.68M |
| Nyxoah | 187.93M |
| Hyloris Pharmaceuticals | 155.12M |